You are here

Circulating Diagnostic Markers of Infectious Disease

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911QY-20-C0114
Agency Tracking Number: C2-0563
Amount: $975,605.67
Phase: Phase II
Program: STTR
Solicitation Topic Code: CBD18A-001
Solicitation Number: 18.A
Timeline
Solicitation Year: 2018
Award Year: 2020
Award Start Date (Proposal Award Date): 2020-09-01
Award End Date (Contract End Date): 2022-08-31
Small Business Information
1024 Roy J. Carver Co-Laboratory 1111 WOI Road, Iowa State University
Ames, IA 50011
United States
DUNS: 832427822
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Manohar John
 President & Chief Scientific Officer
 (781) 244-4505
 mjohn@pathovacs.com
Business Contact
 Manohar John
Phone: (781) 244-4505
Email: mjohn@pathovacs.com
Research Institution
 Iowa State University of Science and Technology
 Manohar John Manohar John
 
Office of Sponsored Programs Aministration 1138 Pearson Hall, 505 Morill Road
Ames, IA 50011
United States

 (781) 244-4505
 Nonprofit college or university
Abstract

Assays for accurate diagnosis of early stages of infection with biothreat agents, on the day of infection or within a few days of infection, will find wide use in both civilian and military applications These diagnostic assays, which are anticipated to be highly specific and sensitive, will add to the repertoire of tools of hospitals and clinics that serve our armed forces personnel deployed on the front lines in diverse geographical regions of the globe, as well infectious disease clinics that cater to civilian populations world-wide. In addition, such assays for early accurate diagnosis of infections caused by the above biothreat agents with the ability to wreak havoc in both humans and animals, will be very attractive for organizations involved in surveillance efforts for prompt and effective management of infections caused by these pathogens. The commercial market for such dual use diagnostic assays is therefore expected to be global.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government